Biotech

All Articles

Editas profit Vertex Cas9 licensing liberties for $57M

.Versus the backdrop of a Cas9 patent fight that rejects to perish, Editas Medicine is cashing in a ...

Ultragenyx modifies genetics therapy application to call up efficacy

.A minority of patients taking Ultragenyx Drug's Wilson condition genetics treatment UX701 have actu...

Biopharma layoff fee stabilizes in Q3: Strong Biotech review

.As summer months heat looks to cool winds, wishes that this year will take common field comfort hav...

J &amp J falls phase 2 dengue prospect in most recent shift coming from vaccines

.Johnson &amp Johnson's deprioritization of its own transmittable condition pipe has stated another ...

Relay loses 10% of team after earlier discharges in July

.Accuracy medicine biotech Relay Therapies is actually dropping about 10% of its own workforce in at...

Pentixapharm scores $22M IPO to allowance radiopharma tests

.Pentixapharm has produced virtually twenty thousand europeans ($ 22 million) coming from an IPO, wi...

Lundbeck faucets Charles Stream for AI-enabled neuro medication breakthrough

.Lundbeck has tapped Charles Stream Laboratories' artificial intelligence functionalities to aid the...

Big pharma, biotech 'will not essentially be cooperative' in AI: S&ampP

.Big Pharma is committing highly in artificial intelligence to reduce growth timelines and foster ad...

I &amp I biotech Triveni raises $115M for preclinical antibodies

.Triveni Biography has actually trapped $115 thousand in series B funds to advance preclinical antit...

IGM rotates coming from cancer cells to autoimmune, agitating C-suite

.IGM Biosciences finished in 2013 giving up team and also simplifying its own cancer cells pipeline....